The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma
Sign Up to like & getrecommendations! Published in 2018 at "British Journal of Cancer"
DOI: 10.1038/bjc.2017.418
Abstract: Rachna T Shroff, Mark Yarchoan, Ashley O’Connor, Denise Gallagher, Marianna L Zahurak, Gary Rosner, Chimela Ohaji, Susan Sartorius-Mergenthaler, Rose Parkinson, Vivek Subbiah, Ralph Zinner and Nilofer S Azad The University of Texas MD Anderson Cancer… read more here.
Keywords: inhibitor; vegf receptor; receptor tyrosine; cancer center ... See more keywords